APA (7th ed.) Citation

E, K., BS, R., F, S., KS, G., M, B., G, M., . . . WE, H. (2025). Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin. Cardiovascular drugs and therapy, 39(2), 325. https://doi.org/10.1007/s10557-023-07538-w

Chicago Style (17th ed.) Citation

E, Krohmer, et al. "Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin." Cardiovascular Drugs and Therapy 39, no. 2 (2025): 325. https://doi.org/10.1007/s10557-023-07538-w.

MLA (9th ed.) Citation

E, Krohmer, et al. "Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin." Cardiovascular Drugs and Therapy, vol. 39, no. 2, 2025, p. 325, https://doi.org/10.1007/s10557-023-07538-w.